BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34131135)

  • 1. Learning mutational signatures and their multidimensional genomic properties with TensorSignatures.
    Vöhringer H; Hoeck AV; Cuppen E; Gerstung M
    Nat Commun; 2021 Jun; 12(1):3628. PubMed ID: 34131135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.
    Chan K; Roberts SA; Klimczak LJ; Sterling JF; Saini N; Malc EP; Kim J; Kwiatkowski DJ; Fargo DC; Mieczkowski PA; Getz G; Gordenin DA
    Nat Genet; 2015 Sep; 47(9):1067-72. PubMed ID: 26258849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signatures of mutational processes in human cancer.
    Alexandrov LB; Nik-Zainal S; Wedge DC; Aparicio SA; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale AL; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinski M; Jäger N; Jones DT; Jones D; Knappskog S; Kool M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt AN; Valdés-Mas R; van Buuren MM; van 't Veer L; Vincent-Salomon A; Waddell N; Yates LR; ; ; ; ; Zucman-Rossi J; Futreal PA; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR
    Nature; 2013 Aug; 500(7463):415-21. PubMed ID: 23945592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An extended APOBEC3A mutation signature in cancer.
    Langenbucher A; Bowen D; Sakhtemani R; Bournique E; Wise JF; Zou L; Bhagwat AS; Buisson R; Lawrence MS
    Nat Commun; 2021 Mar; 12(1):1602. PubMed ID: 33707442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of gene expression and associated mutation profiles of APOBEC3A, APOBEC3B, REV1, UNG, and FHIT with chemosensitivity of cancer cell lines to drug treatment.
    Vural S; Simon R; Krushkal J
    Hum Genomics; 2018 Apr; 12(1):20. PubMed ID: 29642934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion.
    Nowarski R; Kotler M
    Cancer Res; 2013 Jun; 73(12):3494-8. PubMed ID: 23598277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clustered Mutation Signatures Reveal that Error-Prone DNA Repair Targets Mutations to Active Genes.
    Supek F; Lehner B
    Cell; 2017 Jul; 170(3):534-547.e23. PubMed ID: 28753428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring APOBEC3A protein levels in human cancer cells.
    Dananberg A; Maciejowski J
    Methods Cell Biol; 2024; 182():313-327. PubMed ID: 38359985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication.
    Hoopes JI; Cortez LM; Mertz TM; Malc EP; Mieczkowski PA; Roberts SA
    Cell Rep; 2016 Feb; 14(6):1273-1282. PubMed ID: 26832400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types.
    Chen Z; Wen W; Bao J; Kuhs KL; Cai Q; Long J; Shu XO; Zheng W; Guo X
    BMC Med Genomics; 2019 Sep; 12(1):131. PubMed ID: 31533728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.
    Nik-Zainal S; Wedge DC; Alexandrov LB; Petljak M; Butler AP; Bolli N; Davies HR; Knappskog S; Martin S; Papaemmanuil E; Ramakrishna M; Shlien A; Simonic I; Xue Y; Tyler-Smith C; Campbell PJ; Stratton MR
    Nat Genet; 2014 May; 46(5):487-91. PubMed ID: 24728294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of Mutational Signature Analysis with 3D Chromatin Data Unveils Differential AID-Related Mutagenesis in Indolent Lymphomas.
    Sepulveda-Yanez JH; Alvarez-Saravia D; Fernandez-Goycoolea J; Aldridge J; van Bergen CAM; Posthuma W; Uribe-Paredes R; Veelken H; Navarrete MA
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repair of base damage within break-induced replication intermediates promotes kataegis associated with chromosome rearrangements.
    Elango R; Osia B; Harcy V; Malc E; Mieczkowski PA; Roberts SA; Malkova A
    Nucleic Acids Res; 2019 Oct; 47(18):9666-9684. PubMed ID: 31392335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer.
    Liu W; Newhall KP; Khani F; Barlow L; Nguyen D; Gu L; Eng K; Bhinder B; Uppal M; Récapet C; Sboner A; Ross SR; Elemento O; Chelico L; Faltas BM
    Cancer Res; 2023 Feb; 83(4):506-520. PubMed ID: 36480186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC3B cytidine deaminase targets the non-transcribed strand of tRNA genes in yeast.
    Saini N; Roberts SA; Sterling JF; Malc EP; Mieczkowski PA; Gordenin DA
    DNA Repair (Amst); 2017 May; 53():4-14. PubMed ID: 28351647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers.
    DeWeerd RA; Németh E; Póti Á; Petryk N; Chen CL; Hyrien O; Szüts D; Green AM
    Cell Rep; 2022 Mar; 38(12):110555. PubMed ID: 35320711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repair of multiple simultaneous double-strand breaks causes bursts of genome-wide clustered hypermutation.
    Sakofsky CJ; Saini N; Klimczak LJ; Chan K; Malc EP; Mieczkowski PA; Burkholder AB; Fargo D; Gordenin DA
    PLoS Biol; 2019 Sep; 17(9):e3000464. PubMed ID: 31568516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication.
    Seplyarskiy VB; Soldatov RA; Popadin KY; Antonarakis SE; Bazykin GA; Nikolaev SI
    Genome Res; 2016 Feb; 26(2):174-82. PubMed ID: 26755635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The topography of mutational processes in breast cancer genomes.
    Morganella S; Alexandrov LB; Glodzik D; Zou X; Davies H; Staaf J; Sieuwerts AM; Brinkman AB; Martin S; Ramakrishna M; Butler A; Kim HY; Borg Å; Sotiriou C; Futreal PA; Campbell PJ; Span PN; Van Laere S; Lakhani SR; Eyfjord JE; Thompson AM; Stunnenberg HG; van de Vijver MJ; Martens JW; Børresen-Dale AL; Richardson AL; Kong G; Thomas G; Sale J; Rada C; Stratton MR; Birney E; Nik-Zainal S
    Nat Commun; 2016 May; 7():11383. PubMed ID: 27136393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-resolution landscape of mutations in the
    Shen JC; Kamath-Loeb AS; Kohrn BF; Loeb KR; Preston BD; Loeb LA
    Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24779-24785. PubMed ID: 31748270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.